X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (60) 60
index medicus (53) 53
multiple myeloma (41) 41
oncology (34) 34
multiple myeloma - drug therapy (33) 33
male (28) 28
bortezomib (27) 27
female (27) 27
middle aged (27) 27
aged (26) 26
hematology (25) 25
adult (24) 24
antineoplastic combined chemotherapy protocols - therapeutic use (22) 22
care and treatment (21) 21
hematology, oncology and palliative medicine (19) 19
cancer (16) 16
treatment outcome (16) 16
article (15) 15
multiple myeloma - pathology (15) 15
therapy (15) 15
aged, 80 and over (14) 14
transplantation (14) 14
antineoplastic agents - therapeutic use (13) 13
dexamethasone (12) 12
drug therapy (12) 12
lenalidomide (12) 12
prognosis (12) 12
abridged index medicus (11) 11
multiple myeloma - therapy (11) 11
patients (11) 11
stem-cell transplantation (11) 11
thalidomide (11) 11
multiple myeloma - mortality (10) 10
survival (10) 10
analysis (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (9) 9
dexamethasone - administration & dosage (9) 9
health aspects (9) 9
medical and health sciences (9) 9
medicin och hälsovetenskap (9) 9
myeloma (9) 9
proteasome inhibitors (9) 9
recurrence (9) 9
diagnosis (8) 8
disease-free survival (8) 8
patient outcomes (8) 8
research (8) 8
thalidomide - analogs & derivatives (8) 8
bone marrow (7) 7
boronic acids - administration & dosage (7) 7
cell biology (7) 7
immunology (7) 7
neoplasm recurrence, local - drug therapy (7) 7
pyrazines - administration & dosage (7) 7
risk factors (7) 7
survival analysis (7) 7
transplantation, autologous (7) 7
transplants & implants (7) 7
antineoplastic agents - administration & dosage (6) 6
apoptosis (6) 6
boronic acids - therapeutic use (6) 6
carfilzomib (6) 6
clinical medicine (6) 6
drug administration schedule (6) 6
drug dosages (6) 6
drug resistance, neoplasm (6) 6
hemic and lymphatic diseases (6) 6
klinisk medicin (6) 6
lenalidomide plus dexamethasone (6) 6
maximum tolerated dose (6) 6
medical colleges (6) 6
multiple myeloma - diagnosis (6) 6
multiple myeloma - genetics (6) 6
plus dexamethasone (6) 6
proteins (6) 6
pyrazines - therapeutic use (6) 6
biomarkers (5) 5
chemotherapy (5) 5
combination therapy (5) 5
dosage and administration (5) 5
double-blind method (5) 5
elderly-patients (5) 5
internal medicine (5) 5
medicine, general & internal (5) 5
relapse (5) 5
risk (5) 5
stem cell transplantation (5) 5
studies (5) 5
thalidomide - administration & dosage (5) 5
thalidomide - therapeutic use (5) 5
trial (5) 5
administration, oral (4) 4
adolescent (4) 4
age (4) 4
age factors (4) 4
allogeneic transplantation (4) 4
animals (4) 4
cancer patients (4) 4
cancer therapies (4) 4
cells (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 8, pp. e328 - e346
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 11, pp. 1129 - 1140
Journal Article
by Tefferi, Ayalew, MD and Kantarjian, Hagop, MD and Rajkumar, S. Vincent, MD and Baker, Lawrence H., DO and Abkowitz, Jan L., MD and Adamson, John W., MD and Advani, Ranjana Hira, MD and Allison, James, MD and Antman, Karen H., MD and Bast, Robert C., MD and Bennett, John M., MD and Benz, Edward J., MD and Berliner, Nancy, MD and Bertino, Joseph, MD and Bhatia, Ravi, MD and Bhatia, Smita, MD and Bhojwani, Deepa, MD and Blanke, Charles D., MD and Bloomfield, Clara D., MD and Bosserman, Linda, MD and Broxmeyer, Hal E., PhD and Byrd, John C., MD and Cabanillas, Fernando, MD and Canellos, George Peter, MD and Chabner, Bruce A., MD and Chanan-Khan, Asher, MD and Cheson, Bruce, MD and Clarkson, Bayard, MD and Cohn, Susan L., MD and Colon-Otero, Gerardo, MD and Cortes, Jorge, MD and Coutre, Steven, MD and Cristofanilli, Massimo, MD and Curran, Walter J., MD and Daley, George Q., MD, PhD and DeAngelo, Daniel J., MD, PhD and Deeg, H. Joachim, MD and Einhorn, Lawrence H., MD and Erba, Harry P., MD, PhD and Esteva, Francisco J., MD, PhD and Estey, Elihu, MD and Fidler, Isaiah J., DVM, PhD and Foran, James, MD and Forman, Stephen, MD and Freireich, Emil, MD and Fuchs, Charles, MD, MPH and George, James N., MD and Gertz, Morie A., MD and Giralt, Sergio, MD and Golomb, Harvey, MD and Greenberg, Peter, MD and Gutterman, Jordan, MD and Handin, Robert I., MD and Hellman, Samuel, MD and Hoff, Paulo Marcelo, MD and Hoffman, Ronald, MD and Hong, Waun Ki, MD and Horowitz, Mary, MD, MS and Hortobagyi, Gabriel N., MD and Hudis, Clifford, MD and Issa, Jean Pierre, MD and Johnson, Bruce Evan, MD and Kantoff, Philip W., MD and Kaushansky, Kenneth, MD and Khayat, David, MD, PhD and Khuri, Fadlo R., MD and Kipps, Thomas J., MD, PhD and Kripke, Margaret, PhD and Kyle, Robert A., MD and Larson, Richard A., MD and Lawrence, Theodore S., MD, PhD and Levine, Ross, MD and Link, Michael P., MD and Lippman, Scott M., MD and Lonial, Sagar, MD and Lyman, Gary H., MD, MPH and Markman, Maurie, MD and Mendelsohn, John, MD and Meropol, Neal J., MD and Messinger, Yoav, MD and Mulvey, Therese M., MD and O’Brien, Susan, MD and Perez-Soler, Roman, MD and Pollock, Raphael, MD, PhD and Prchal, Josef, MD and Press, Oliver, MD, PhD and Radich, Jerald, MD and Rai, Kanti, MD and Rosenberg, Saul A., MD and Rowe, Jacob M., MD and Rugo, Hope, MD and Runowicz, Carolyn D., MD and Sandmaier, Brenda M., MD and Saven, Alan, MD and Schafer, Andrew I., MD and Schiffer, Charles, MD and Sekeres, Mikkael A., MD, MS and Silver, Richard T., MD and Siu, Lillian L., MD and Steensma, David P., MD and ...
Mayo Clinic Proceedings, ISSN 0025-6196, 2015, Volume 90, Issue 8, pp. 996 - 1000
Journal Article
American Heart Journal, ISSN 0002-8703, 2009, Volume 158, Issue 1, pp. 53 - 60.e1
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 387, Issue 10027, pp. 1551 - 1560
Summary Background New treatment options are needed for patients with multiple myeloma that is refractory to proteasome inhibitors and immunomodulatory drugs.... 
Internal Medicine | SURVIVAL | MEDICINE, GENERAL & INTERNAL | RISK | MULTICENTER | THERAPY | ELOTUZUMAB | Drug Administration Schedule | United States | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Kaplan-Meier Estimate | Neoplasm Recurrence, Local - drug therapy | Antibodies, Monoclonal - therapeutic use | Drug Resistance, Neoplasm | Male | Treatment Outcome | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Spain | Canada | Disease-Free Survival | Multiple Myeloma - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Agents - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adult | Female | Aged | Drugs | Medical colleges | Biological products | Multiple myeloma | Monoclonal antibodies | Product development | Lymphomas | Drug therapy | Care and treatment | Analysis | Studies | Protease inhibitors | Hematology | Stem cells | Cytotoxicity | Patients | Drug dosages | Slopes | Therapy | Schedules | Intravenous administration | Stem cell transplantation | Transplantation | Drug screening | Immunosuppressive agents | Randomization | CD38 antigen | Autografts | Anemia | Immunomodulation | Research & development--R&D | FDA approval | Survival | Proteasome inhibitors | Asthma | Refractory materials | Inhibitors | Interactive systems | Response rates
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 12, pp. e538 - e548
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 11, pp. 1195 - 1206
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1503 - 1512
Journal Article